February 13, 2020 / 10:37 PM / 8 days ago

BRIEF-Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial

Feb 13 (Reuters) - Hemostemix Inc:

* ASPIRE HEALTH SCIENCE FILES SUPPLEMENTAL MOTION FOR EXPEDITED HEARING IN LAWSUIT AGAINST HEMOSTEMIX INC. AND SUSPENDS PATIENT RECRUITMENT FOR HEMOSTEMIX CLI PHASE 2 CLINICAL TRIAL

* ASPIRE HEALTH SCIENCE - FILES SUPPLEMENTAL MOTION FOR EXPEDITED HEARING IN LAWSUIT AGAINST CO

* ASPIRE HEALTH SCIENCE - SUSPENDS PATIENT RECRUITMENT FOR HEMOSTEMIX CLI PHASE 2 CLINICAL TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below